TR-14035
CAS No. 232271-19-1
TR-14035 ( TR 14035;TR14035 )
Catalog No. M13660 CAS No. 232271-19-1
A potent, orally bioavailable, dual α4β7/α4β1 integrin antagonist with IC50 of 7/87 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 105 | In Stock |
|
5MG | 160 | In Stock |
|
10MG | 260 | In Stock |
|
25MG | 470 | In Stock |
|
50MG | 680 | In Stock |
|
100MG | 954 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTR-14035
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, orally bioavailable, dual α4β7/α4β1 integrin antagonist with IC50 of 7/87 nM.
-
DescriptionA potent, orally bioavailable, dual α4β7/α4β1 integrin antagonist with IC50 of 7/87 nM; blocks the binding of human α4β7 to an (125)I-MAdCAM-Ig fusion protein with IC50 of 0.75 nM; suppresses antigen-induced lung interleukin (IL)-5 mRNA upregulation, inhibits the leukocyte rolling flux, adhesion and emigration induced by IL4 in rats.Asthma Phase 1 Discontinued
-
SynonymsTR 14035;TR14035
-
PathwayCell Cycle/DNA Damage
-
TargetIntegrin
-
Recptorα4β7integrin;α4β1integrin
-
Research AreaInflammation/Immunology
-
IndicationAsthma
Chemical Information
-
CAS Number232271-19-1
-
Formula Weight474.33
-
Molecular FormulaC24H21Cl2NO5
-
Purity>98% (HPLC)
-
SolubilityDMSO:≥ 41 mg/mL
-
SMILESO=C(O)[C@H](CC1=CC=C(C2=C(OC)C=CC=C2OC)C=C1)NC(C3=C(Cl)C=CC=C3Cl)=O
-
Chemical Name[1,1'-Biphenyl]-4-propanoic acid, α-[(2,6-dichlorobenzoyl)amino]-2',6'-dimethoxy-,(αS)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Sircar I, et al. Bioorg Med Chem. 2002 Jun;10(6):2051-66.
2. Cortijo J, et al. Br J Pharmacol. 2006 Mar;147(6):661-70.
3. Tsuda-Tsukimoto M, et al. Pharm Res. 2006 Nov;23(11):2646-56.
2. Cortijo J, et al. Br J Pharmacol. 2006 Mar;147(6):661-70.
3. Tsuda-Tsukimoto M, et al. Pharm Res. 2006 Nov;23(11):2646-56.
molnova catalog
related products
-
α2β1 integrin-IN-15
α2β1 integrin-IN-15 highly potent, selective, allosteric small-molecule inhibitor of integrin α2β1 with IC50 of 12 nM.
-
GSK-3008348 hydrochl...
GSK-3008348 hydrochloride is a novel potent, selective integrin αvβ6 antagonist for the treatment of idiopathic pulmonary fibrosis (IPF).
-
P11
Potent antagonist of the integrin αvβ3-vitronectin interaction (IC50 = 25.72 nM). Blocks proliferation and induces apoptosis in HUVECs; antiangiogenic.